News

Sep 2024   Registrations of clinical trials performing advanced cell therapy with perinatal cells have returned to pre-pandemic levels. When perinatal blood is used in trials to treat hematology/oncology disorders, it is usually as a source material to derive immunotherapy cells. Trials of perinatal MSC continue to be spread among many indications for use.

Sep 2024   Cryo-Cell has launched operations in a 56,000 sq ft building located near Duke University Medical Center. Going forward, Cryo-Cell will split their activities between Oldsmar, Florida, and Durham, North Carolina. The state-of-the-art storage facility in Durham now offers third party storage under the name ExtraVault. When completed, the Durham facility will also offer cellular manufacturing and clinical services.

Aug 2024   Whole Genome Sequencing (WGS) is gradually replacing targeted genetic testing in medical research, public health programs, and direct to consumer health tests. In this article we explain why WGS is both the most accurate form of screening and can also be the most economical method of screening. Over 7,000 genetic disorders have been identified to date, many of them for rare diseases that are otherwise hard to diagnose. When parents request genomic screening for their child, they can learn about health risks that manifest in childhood, whereas adults can learn about any health risk if they so choose.

Aug 2024   A recent NYT article about cord blood banking contained very misleading statements and we have responded with corrections. Topics covered include: the percentage of cord blood units (CBU) that are contaminated, the reasons privately banked CBU are rejected from clinical trials, the odds of using cord blood for a transplant versus for clinical trial, the number of children that have been treated with privately banked cord blood, and more.

Jul 2024   The purpose of this article is to explain that, under standard operating procedures, cord blood banks normally have multiple overlapping levels of safeguards in effect to protect the samples in their storage tanks.

Jul 2024   In order to align with an upcoming clinical trial that will give unrelated cord blood to children with cerebral palsy, the Duke EAP is now offering comparable compassionate treatment to those children with cerebral palsy that do not qualify for the trial.

Jul 2024   Mason Shaffer received a cord blood transplant when he was still an infant for the rare metabolic condition Malignant Infantile Osteopetrosis. He is now living his best life as a teenager. Mason is an honors student in high school and he is very active in sports.

Jun 2024   The edge where the placenta attaches to the wall of the uterus, called the placenta decidua, contains maternal tissues. Recently, researchers in Sweden published a paper claiming that mesenchymal stromal cells from the decidua are the most effective cell therapy for graft versus host disease.  

Jun 2024   During 2023 the laboratories of cord blood banks around the world were hit with a double punch: Banks that were using Sepax were forced to change their processing method. Simultaneously, there is a shortage of the hetastarch reagent for manually depleting red cells from cord blood. As banks reconsider alternative methods of cord blood processing, the PrepaCyte®-CB reagent is now available in a semi-automated system.

May 2024   StemCyte's CEO explains why the company is ready for an IPO. In addition to operating a multi-national hybrid cord blood bank, StemCyte is also manufacturing immunotherapies from cord blood and is one of the industry's leaders in running clinical trials with cord blood.